Although the mechanism underlying the higher neoantigen load in TNBC compared with non-TNBC has not been elucidated, a possible cause is that, compared with luminal type breast cancer, which has specific tumorigenic factors such as signalling pathways via hormone receptors, TNBC requires a higher rate of mutations to gain tumour-driving mutations. This evidence concerns the gene NR4A1 and breast cancer.